Computational analysis of drug like candidates against Neuraminidase of Human Influenza A virus subtypes
Influenza virus is an enveloped virus having segmented genome, coded by eight (negative-sense) RNA segments. The RNA segments are packed in a nucleocapsid protein. Neuraminidase (NA), an exosialidase, is the major antigen as well as vital virulence factor of the virus and is coded by the 6th segment...
Saved in:
Published in | Informatics in medicine unlocked Vol. 18; p. 100284 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
2020
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Influenza virus is an enveloped virus having segmented genome, coded by eight (negative-sense) RNA segments. The RNA segments are packed in a nucleocapsid protein. Neuraminidase (NA), an exosialidase, is the major antigen as well as vital virulence factor of the virus and is coded by the 6th segment of RNA. Eleven subtypes of NA are characterized for influenza A and the N1–N9 are divided into two phylogenic groups. NA is an active target for development of potent antivirals or Neuraminidase inhibitors (NAIs), which are reported to interact with multiple conserved residues in the active site of NA resulting in inhibition of virion release and prevention of viral spread to nearby cells. The current computational study focuses on docking of eleven different drug-like molecules including the known NAIs such as oseltamivir and zanamivir against crystal structures of NA of human Influenza A virus subtypes of both phylogenic groups. The docking results of this study indicated that zanamivir was the most active drug candidate against various NA subtypes followed by laninamivir. The study provides insights on interactions as well as cross-reactivity between lead compounds and NA proteins of various influenza subtypes. Observations on the efficacy of these NAIs assessed by the computational study have to be validated through in vitro and in vivo studies for successfully translating them as potential therapeutic agents to treat infection by various subtypes of influenza. |
---|---|
AbstractList | Influenza virus is an enveloped virus having segmented genome, coded by eight (negative-sense) RNA segments. The RNA segments are packed in a nucleocapsid protein. Neuraminidase (NA), an exosialidase, is the major antigen as well as vital virulence factor of the virus and is coded by the 6th segment of RNA. Eleven subtypes of NA are characterized for influenza A and the N1–N9 are divided into two phylogenic groups. NA is an active target for development of potent antivirals or Neuraminidase inhibitors (NAIs), which are reported to interact with multiple conserved residues in the active site of NA resulting in inhibition of virion release and prevention of viral spread to nearby cells. The current computational study focuses on docking of eleven different drug-like molecules including the known NAIs such as oseltamivir and zanamivir against crystal structures of NA of human Influenza A virus subtypes of both phylogenic groups. The docking results of this study indicated that zanamivir was the most active drug candidate against various NA subtypes followed by laninamivir. The study provides insights on interactions as well as cross-reactivity between lead compounds and NA proteins of various influenza subtypes. Observations on the efficacy of these NAIs assessed by the computational study have to be validated through in vitro and in vivo studies for successfully translating them as potential therapeutic agents to treat infection by various subtypes of influenza. Influenza virus is an enveloped virus having segmented genome, coded by eight (negative-sense) RNA segments. The RNA segments are packed in a nucleocapsid protein. Neuraminidase (NA), an exosialidase, is the major antigen as well as vital virulence factor of the virus and is coded by the 6th segment of RNA. Eleven subtypes of NA are characterized for influenza A and the N1–N9 are divided into two phylogenic groups. NA is an active target for development of potent antivirals or Neuraminidase inhibitors (NAIs), which are reported to interact with multiple conserved residues in the active site of NA resulting in inhibition of virion release and prevention of viral spread to nearby cells. The current computational study focuses on docking of eleven different drug-like molecules including the known NAIs such as oseltamivir and zanamivir against crystal structures of NA of human Influenza A virus subtypes of both phylogenic groups. The docking results of this study indicated that zanamivir was the most active drug candidate against various NA subtypes followed by laninamivir. The study provides insights on interactions as well as cross-reactivity between lead compounds and NA proteins of various influenza subtypes. Observations on the efficacy of these NAIs assessed by the computational study have to be validated through in vitro and in vivo studies for successfully translating them as potential therapeutic agents to treat infection by various subtypes of influenza. Keywords: Influenza A virus, Computational analysis, Docking, Neuraminidase, Antivirals, Drugs |
ArticleNumber | 100284 |
Author | Devadasan, Velmurugan Srinivasan, Sivasubramanian Krishnasamy, Kaveri Selvaraj, Gracy Fathima Piramanayagam, Shanmugavel Hassan, Sameer |
Author_xml | – sequence: 1 givenname: Gracy Fathima surname: Selvaraj fullname: Selvaraj, Gracy Fathima organization: Department of Virology, King Institute of Preventive Medicine and Research, Chennai, Tamilnadu, India – sequence: 2 givenname: Shanmugavel surname: Piramanayagam fullname: Piramanayagam, Shanmugavel organization: Department of Bioinformatics, Bharathiar University, Coimbatore, Tamilnadu, India – sequence: 3 givenname: Velmurugan surname: Devadasan fullname: Devadasan, Velmurugan organization: CAS in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai, Tamilnadu, India – sequence: 4 givenname: Sameer surname: Hassan fullname: Hassan, Sameer organization: University of Gothenberg, Sweden – sequence: 5 givenname: Kaveri surname: Krishnasamy fullname: Krishnasamy, Kaveri email: kaveriraj1967@gmail.com organization: Department of Virology, King Institute of Preventive Medicine and Research, Chennai, Tamilnadu, India – sequence: 6 givenname: Sivasubramanian surname: Srinivasan fullname: Srinivasan, Sivasubramanian organization: Department of Virology, King Institute of Preventive Medicine and Research, Chennai, Tamilnadu, India |
BookMark | eNp9UMtOwzAQtBBIPD-Am3-gxY84jsUJVTwqIbjA2do4m-KSOJWdIJWvx6UIceIyuzvaGe3OKTkMQ0BCLjmbc8bLq_Xc99NcMG7yzERVHJATIZWYGV5Uh3_6Y3KR0poxxnUplVYn5G0x9JtphNEPAToKGbbJJzq0tInTinb-HamD0PgGRkwUVuBDGukTThF6HzKdcLf9MPUQ6DK03YThE-gN_fBxSjRN9bjdYDonRy10CS9-6hl5vbt9WTzMHp_vl4ubx5mTghczXoEsi6Y1plKudrqVotQlFNCIjLx0WkmnmEEtGDBZo9ICQNTAisxVTp6R5d63GWBtN9H3ELd2AG-_iSGuLMTRuw6t4M5Ihc6UqiokanBCgKkbpbjSxkD24nsvF4eUIra_fpzZXfJ2bXPydpe83SefNdd7DeYnPzxGm5zH4LDxEd2Yr_D_qL8AjiaNuw |
CitedBy_id | crossref_primary_10_1007_s00894_021_05005_7 crossref_primary_10_3390_nu14020274 crossref_primary_10_1016_j_sciaf_2024_e02264 crossref_primary_10_1016_j_heliyon_2022_e10101 crossref_primary_10_1080_07391102_2023_2251065 |
Cites_doi | 10.1021/jm800455g 10.1016/S1473-3099(11)70008-1 10.1007/s11434-011-4517-9 10.1038/303035a0 10.1038/nature05114 10.1371/journal.ppat.1002249 10.1371/journal.ppat.1003657 10.1128/JVI.03122-15 10.1073/pnas.1116200109 10.1107/S0108767307035623 10.1038/303041a0 10.1110/ps.41801 10.1177/0091270012440280 10.17221/6746-VETMED 10.1096/fj.08-119131 10.1002/rmv.352 10.3389/fmicb.2016.00450 10.1006/jmbi.1996.0897 10.1126/science.1222213 10.1107/S0907444904026460 10.1016/0022-2836(91)80068-6 10.3851/IMP1194 10.3389/fmicb.2019.00039 10.1093/infdis/jiq010 10.1128/AAC.49.11.4515-4520.2005 10.1111/j.1750-2659.2011.00304.x 10.1038/mi.2017.16 10.1371/journal.ppat.1000786 10.1093/nar/29.1.221 10.1128/AAC.00731-09 10.1086/514178 10.1007/s11427-010-4010-8 10.1002/cmdc.201200155 10.1002/prot.340140302 10.1016/S0021-9258(18)68802-7 10.1002/pro.5560040606 10.1111/irv.12047 10.1093/protein/8.2.127 10.1146/annurev.biochem.78.082207.084029 10.1093/bioinformatics/btl158 10.1038/msb.2011.75 10.1093/molbev/msy096 10.1016/j.virol.2010.04.030 10.1016/j.chom.2015.02.012 10.1021/jm00017a005 10.2147/DDDT.S176220 10.1186/1758-2946-1-12 |
ContentType | Journal Article |
Copyright | 2019 |
Copyright_xml | – notice: 2019 |
DBID | 6I. AAFTH AAYXX CITATION DOA |
DOI | 10.1016/j.imu.2019.100284 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2352-9148 |
ExternalDocumentID | oai_doaj_org_article_21c935ec965843e7ac22a9bd5515799a 10_1016_j_imu_2019_100284 S2352914819303016 |
GroupedDBID | 0R~ 0SF 6I. AACTN AAEDW AAFTH AALRI AAXUO ABMAC ACGFS ADBBV AEXQZ AFTJW AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ BCNDV EBS EJD FDB GROUPED_DOAJ KQ8 M41 M~E NCXOZ O9- OK1 RIG ROL SSZ AAYXX ADVLN AFJKZ AKRWK CITATION |
ID | FETCH-LOGICAL-c3214-18a364df9985cbc7f32676a4ad26a416c753c509e720a03be572aa2ba049e78c3 |
IEDL.DBID | DOA |
ISSN | 2352-9148 |
IngestDate | Tue Oct 22 15:12:22 EDT 2024 Thu Sep 26 15:57:05 EDT 2024 Tue Jul 25 21:04:10 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Drugs Docking Computational analysis Influenza A virus Neuraminidase Antivirals |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3214-18a364df9985cbc7f32676a4ad26a416c753c509e720a03be572aa2ba049e78c3 |
OpenAccessLink | https://doaj.org/article/21c935ec965843e7ac22a9bd5515799a |
ParticipantIDs | doaj_primary_oai_doaj_org_article_21c935ec965843e7ac22a9bd5515799a crossref_primary_10_1016_j_imu_2019_100284 elsevier_sciencedirect_doi_10_1016_j_imu_2019_100284 |
PublicationCentury | 2000 |
PublicationDate | 2020 2020-00-00 2020-01-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – year: 2020 text: 2020 |
PublicationDecade | 2020 |
PublicationTitle | Informatics in medicine unlocked |
PublicationYear | 2020 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Vavricka, Li, Wu, Qi, Wang (bib30) 2011; 7 WHO (bib2) 2018 Mishin, Hayden, Gubareva (bib43) 2005; 49 Krissinel, Henrick (bib36) 2004; 60 Vavricka, Liu, Li, Shi, Wu, Sun (bib6) 2011; 56 Smith, Colman, Von Itzstein, Danylec, Varghese (bib31) 2001; 10 Luo, Air, Brouillette (bib26) 1997; 176 Colman (bib21) 2009; 78 Cole, Nissink, Taylor (bib41) 2005 Sun, Shi, Zhang, Li, Liu, Vavricka (bib7) 2010; 53 Pizzorno, Bouhy, Abed, Boivin (bib42) 2011; 203 Houser, Subbarao (bib13) 2015; 17 Alame, Massaad, Zaraket (bib29) 2016; 7 Varghese, McKimm-Breschkin, Caldwell, Kortt, Colman (bib23) 1992; 14 Bossart, Babu, Cook, Air, Laver (bib17) 1988; 263 Eyer, Hruska (bib47) 2013; 58 Tong, Zhu, Li, Shi, Zhang, Bourgeois (bib15) 2013; 9 Sievers, Wilm, Dineen, Gibson, Karplus, Li (bib33) 2011; 7 Li, Godzik, Cd-hit (bib34) 2006; 22 Jones, Willett, Glen, Leach, Taylor (bib40) 1997 McAuley, Gilbertson, Trifkovic, Brown, McKimm-Breschkin (bib19) 2019; 10 Singh, Jedrzejas, Air, Luo, Laver, Brouillette (bib25) 1995; 38 Berman (bib27) 2008; 64 Kamali, Holodniy (bib50) 2013; 6 McKimm-Breschkin (bib28) 2012; 7 Gessner, Shindo, Briand (bib1) 2011; 11 Varghese, Colman (bib22) 1991; 221 Wagner, Matrosovich, Klenk (bib4) 2002; 12 Ferguson, Olivier, Genova, Epperson, Smith, Schneider (bib3) 2016; 90 An, Lee, Law, Yang, Poon, Lau (bib20) 2009; 52 Moules, Ferraris, Terrier, Giudice, Yver, Rolland (bib12) 2010; 404 Chairat, Tarning, White, Lindegardh (bib48) 2013; 53 Feng, Ye, Li, Zhang, Wang, Zhao (bib49) 2012; 7 Air (bib8) 2012; 6 Kumar, Stecher, Li, Knyaz, Tamura, MEGA (bib35) 2018; 35 Varghese, Laver, Colman (bib11) 1983; 303 Kesimer, Scull, Brighton, Demaria, Burns, O'Neal (bib9) 2009; 23 Laskowski (bib38) 2001; 29 Tong, Li, Rivailler, Conrardy, Castillo, Chen (bib14) 2012; 109 Wallace, Laskowski, Thornton (bib37) 1995; 8 Jagger, Wise, Kash, Walters, Wills, Xiao (bib5) 2012; 337 Tashiro, McKimm-Breschkin, Saito, Klimov, Macken, Zambon (bib46) 2009; 14 Koyama, Takahashi, Oitate, Nakai, Takakusa, Miura (bib44) 2009; 53 McAuley, Corcilius, Tan, Payne, McGuckin, Brown (bib10) 2017; 10 Colman, Varghese, Laver (bib18) 1983; 303 Russell, Haire, Stevens, Collins, Lin, Blackburn (bib16) 2006; 443 Varghese, Epa, Colman (bib24) 1995; 4 Kiso, Kubo, Ozawa, Le, Nidom, Yamashita (bib45) 2010; 6 Rahman, Bashton, Holliday, Schrader, Thornton (bib39) 2009; 1 Glanz, Myasoedova, Grechko, Orekhov (bib32) 2018 Ferguson (10.1016/j.imu.2019.100284_bib3) 2016; 90 Alame (10.1016/j.imu.2019.100284_bib29) 2016; 7 Chairat (10.1016/j.imu.2019.100284_bib48) 2013; 53 Kamali (10.1016/j.imu.2019.100284_bib50) 2013; 6 Koyama (10.1016/j.imu.2019.100284_bib44) 2009; 53 McKimm-Breschkin (10.1016/j.imu.2019.100284_bib28) 2012; 7 Russell (10.1016/j.imu.2019.100284_bib16) 2006; 443 Colman (10.1016/j.imu.2019.100284_bib18) 1983; 303 Jones (10.1016/j.imu.2019.100284_bib40) 1997 Vavricka (10.1016/j.imu.2019.100284_bib30) 2011; 7 Wallace (10.1016/j.imu.2019.100284_bib37) 1995; 8 Mishin (10.1016/j.imu.2019.100284_bib43) 2005; 49 Laskowski (10.1016/j.imu.2019.100284_bib38) 2001; 29 WHO (10.1016/j.imu.2019.100284_bib2) 2018 Kumar (10.1016/j.imu.2019.100284_bib35) 2018; 35 Eyer (10.1016/j.imu.2019.100284_bib47) 2013; 58 Li (10.1016/j.imu.2019.100284_bib34) 2006; 22 Bossart (10.1016/j.imu.2019.100284_bib17) 1988; 263 Varghese (10.1016/j.imu.2019.100284_bib11) 1983; 303 Vavricka (10.1016/j.imu.2019.100284_bib6) 2011; 56 Moules (10.1016/j.imu.2019.100284_bib12) 2010; 404 McAuley (10.1016/j.imu.2019.100284_bib19) 2019; 10 Houser (10.1016/j.imu.2019.100284_bib13) 2015; 17 Tashiro (10.1016/j.imu.2019.100284_bib46) 2009; 14 Gessner (10.1016/j.imu.2019.100284_bib1) 2011; 11 Smith (10.1016/j.imu.2019.100284_bib31) 2001; 10 An (10.1016/j.imu.2019.100284_bib20) 2009; 52 Varghese (10.1016/j.imu.2019.100284_bib24) 1995; 4 Kesimer (10.1016/j.imu.2019.100284_bib9) 2009; 23 Tong (10.1016/j.imu.2019.100284_bib15) 2013; 9 McAuley (10.1016/j.imu.2019.100284_bib10) 2017; 10 Glanz (10.1016/j.imu.2019.100284_bib32) 2018 Kiso (10.1016/j.imu.2019.100284_bib45) 2010; 6 Varghese (10.1016/j.imu.2019.100284_bib23) 1992; 14 Tong (10.1016/j.imu.2019.100284_bib14) 2012; 109 Singh (10.1016/j.imu.2019.100284_bib25) 1995; 38 Air (10.1016/j.imu.2019.100284_bib8) 2012; 6 Varghese (10.1016/j.imu.2019.100284_bib22) 1991; 221 Luo (10.1016/j.imu.2019.100284_bib26) 1997; 176 Colman (10.1016/j.imu.2019.100284_bib21) 2009; 78 Sun (10.1016/j.imu.2019.100284_bib7) 2010; 53 Berman (10.1016/j.imu.2019.100284_bib27) 2008; 64 Rahman (10.1016/j.imu.2019.100284_bib39) 2009; 1 Jagger (10.1016/j.imu.2019.100284_bib5) 2012; 337 Cole (10.1016/j.imu.2019.100284_bib41) 2005 Pizzorno (10.1016/j.imu.2019.100284_bib42) 2011; 203 Feng (10.1016/j.imu.2019.100284_bib49) 2012; 7 Krissinel (10.1016/j.imu.2019.100284_bib36) 2004; 60 Sievers (10.1016/j.imu.2019.100284_bib33) 2011; 7 Wagner (10.1016/j.imu.2019.100284_bib4) 2002; 12 |
References_xml | – volume: 263 start-page: 6421 year: 1988 end-page: 6423 ident: bib17 article-title: Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40 publication-title: J Biol Chem contributor: fullname: Laver – volume: 53 start-page: 4845 year: 2009 end-page: 4851 ident: bib44 article-title: CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favourable long-retention profile in the mouse respiratory tract publication-title: Antimicrob Agents Chemother contributor: fullname: Miura – year: 2018 ident: bib2 article-title: Influenza (seasonal) fact sheet contributor: fullname: WHO – volume: 10 start-page: 1581 year: 2017 end-page: 1593 ident: bib10 article-title: The cell surface mucin MUC1 limits the severity of influenza A virus infection publication-title: Mucosal Immunol contributor: fullname: Brown – volume: 4 start-page: 1081 year: 1995 end-page: 1087 ident: bib24 article-title: Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase publication-title: Protein Sci contributor: fullname: Colman – volume: 49 start-page: 4515 year: 2005 end-page: 4520 ident: bib43 article-title: Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors publication-title: Antimicrob Agents Chemother contributor: fullname: Gubareva – volume: 38 start-page: 3217 year: 1995 end-page: 3225 ident: bib25 article-title: Structure based inhibitors of Influenza virus sialidase. A benzoic acid lead with novel interaction publication-title: J Med Chem contributor: fullname: Brouillette – volume: 7 start-page: 450 year: 2016 ident: bib29 article-title: Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections publication-title: Front Microbiol contributor: fullname: Zaraket – year: 2005 ident: bib41 publication-title: Protein-ligand docking and virtual screening with GOLD in virtual screening in drug discovery contributor: fullname: Taylor – volume: 22 start-page: 1658 year: 2006 end-page: 1659 ident: bib34 article-title: A fast program for clustering and comparing large sets of protein or nucleotide sequences publication-title: Bioinformatics contributor: fullname: Cd-hit – volume: 23 start-page: 1858 year: 2009 end-page: 1868 ident: bib9 article-title: Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense publication-title: FASEB J contributor: fullname: O'Neal – volume: 303 start-page: 41 year: 1983 end-page: 44 ident: bib18 article-title: Structure of the catalytic and antigenic sites in influenza virus neuraminidase publication-title: Nature contributor: fullname: Laver – volume: 7 start-page: 539 year: 2011 ident: bib33 article-title: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega publication-title: Mol Syst Biol contributor: fullname: Li – volume: 9 year: 2013 ident: bib15 article-title: New world bats harbor diverse influenza A viruses publication-title: PLoS Pathog contributor: fullname: Bourgeois – volume: 56 start-page: 1747 year: 2011 end-page: 1752 ident: bib6 article-title: Special features of the 2009 pandemic swine-origin influenza AH1N1 hemagglutinin and neuraminidase publication-title: Chin Sci Bull contributor: fullname: Sun – volume: 109 start-page: 4269 year: 2012 end-page: 4274 ident: bib14 article-title: A distinct lineage of influenza a virus from bats publication-title: Proc Natl Acad Sci U S A contributor: fullname: Chen – volume: 7 year: 2011 ident: bib30 article-title: Structural and functional analysis of Laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA Inhibition publication-title: PLoS Pathog contributor: fullname: Wang – volume: 35 start-page: 1547 year: 2018 end-page: 1549 ident: bib35 article-title: Molecular evolutionary genetics analysis across computing platforms publication-title: Mol Biol Evol contributor: fullname: MEGA – start-page: 3431 year: 2018 end-page: 3437 ident: bib32 article-title: Inhibition of sialidase activity as a therapeutic approach publication-title: Drug Des Dev Ther contributor: fullname: Orekhov – volume: 78 start-page: 95 year: 2009 end-page: 118 ident: bib21 article-title: New antivirals and drug resistance publication-title: Annu Rev Biochem contributor: fullname: Colman – volume: 53 start-page: 119 year: 2013 end-page: 139 ident: bib48 article-title: Pharmacokinetic properties of anti- influenza neuraminidase inhibitors publication-title: J Clin Pharmacol contributor: fullname: Lindegardh – volume: 52 start-page: 2667 year: 2009 end-page: 2672 ident: bib20 article-title: A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase publication-title: J Med Chem contributor: fullname: Lau – volume: 17 start-page: 295 year: 2015 end-page: 300 ident: bib13 article-title: Influenza vaccines: challenges and solutions publication-title: Cell Host Microbe contributor: fullname: Subbarao – volume: 6 start-page: 245 year: 2012 end-page: 256 ident: bib8 article-title: Influenza neuraminidase publication-title: Influenza Other Respir Viruses contributor: fullname: Air – volume: 303 start-page: 35 year: 1983 end-page: 40 ident: bib11 article-title: Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A publication-title: Nature contributor: fullname: Colman – volume: 404 start-page: 215 year: 2010 end-page: 224 ident: bib12 article-title: In vitro characterization of naturally occurring influenza H3NA-viruses lacking the NA gene segment: toward a new mechanism of viral resistance? publication-title: Virology contributor: fullname: Rolland – volume: 203 start-page: 25 year: 2011 end-page: 31 ident: bib42 article-title: Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors publication-title: J Infect Dis contributor: fullname: Boivin – volume: 176 start-page: S62 year: 1997 end-page: S65 ident: bib26 article-title: Design of aromatic inhibitors of influenza virus neuraminidase publication-title: J Infect Dis contributor: fullname: Brouillette – volume: 53 start-page: 633 year: 2010 end-page: 642 ident: bib7 article-title: silico characterization of the functional and structural modules of the hemagglutinin protein from the swine-origin influenza virus A (H1N1)-2009 publication-title: Sci China Life Sci contributor: fullname: Vavricka – volume: 64 start-page: 88 year: 2008 end-page: 95 ident: bib27 article-title: The protein Data Bank: a historical perspective publication-title: Acta Crystallogr A Found Crystallogr contributor: fullname: Berman – start-page: 727 year: 1997 end-page: 748 ident: bib40 article-title: Development and validation of a genetic algorithm for flexible docking publication-title: J Mol Biol contributor: fullname: Taylor – volume: 443 start-page: 45 year: 2006 end-page: 49 ident: bib16 article-title: The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design publication-title: Nature contributor: fullname: Blackburn – volume: 7 start-page: 25 year: 2012 end-page: 36 ident: bib28 article-title: Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance publication-title: Influenza Other Respir Viruses contributor: fullname: McKimm-Breschkin – volume: 6 year: 2010 ident: bib45 article-title: Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses publication-title: PLoS Pathog contributor: fullname: Yamashita – volume: 12 start-page: 159 year: 2002 end-page: 166 ident: bib4 article-title: Functional balance between haemagglutinin and neuraminidase in influenza virus infections publication-title: Rev Med Virol contributor: fullname: Klenk – volume: 337 start-page: 199 year: 2012 end-page: 204 ident: bib5 article-title: An overlapping protein-coding region in influenza A virus segment 3 modulates the host response publication-title: Science contributor: fullname: Xiao – volume: 60 start-page: 2256 year: 2004 end-page: 2268 ident: bib36 article-title: Secondary-structure matching (SSM), a new tool for fast Protein structure alignment in three dimensions publication-title: Acta Crystallogr D Biol Crystallogr contributor: fullname: Henrick – volume: 1 start-page: 12 year: 2009 ident: bib39 article-title: Software: small molecule Subgraph detector (SMSD) toolkit publication-title: J Cheminf contributor: fullname: Thornton – volume: 29 start-page: 221 year: 2001 end-page: 222 ident: bib38 article-title: PDBsum: summaries and analyses of PDB structures publication-title: Nucleic Acids Res contributor: fullname: Laskowski – volume: 90 start-page: 5636 year: 2016 end-page: 5642 ident: bib3 article-title: Pathogenesis of influenza D virus in cattle publication-title: J Virol contributor: fullname: Schneider – volume: 7 start-page: 1527 year: 2012 end-page: 1536 ident: bib49 article-title: Recent advances in neuraminidase inhibitor development as anti-influenza drugs publication-title: ChemMedChem contributor: fullname: Zhao – volume: 221 start-page: 473 year: 1991 end-page: 486 ident: bib22 article-title: Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution publication-title: J Mol Biol contributor: fullname: Colman – volume: 11 start-page: 223 year: 2011 end-page: 235 ident: bib1 article-title: Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review publication-title: Lancet Infect Dis contributor: fullname: Briand – volume: 8 start-page: 127 year: 1995 end-page: 134 ident: bib37 article-title: LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions publication-title: Protein Eng contributor: fullname: Thornton – volume: 58 start-page: 113 year: 2013 end-page: 185 ident: bib47 article-title: Antiviral agents targeting the influenza virus: a review and publication analysis publication-title: Vet Med contributor: fullname: Hruska – volume: 10 start-page: 39 year: 2019 ident: bib19 article-title: Influenza virus neuraminidase structure and functions publication-title: Front Microbiol contributor: fullname: McKimm-Breschkin – volume: 14 start-page: 327 year: 1992 end-page: 332 ident: bib23 article-title: The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor publication-title: Proteins contributor: fullname: Colman – volume: 6 start-page: 187 year: 2013 end-page: 198 ident: bib50 article-title: Influenza treatment and prophylaxis with neuraminidase inhibitors: a review publication-title: Infect Drug Resist contributor: fullname: Holodniy – volume: 10 start-page: 689 year: 2001 end-page: 696 ident: bib31 article-title: Analysis of inhibitor binding in influenza virus neuraminidase publication-title: Protein Sci contributor: fullname: Varghese – volume: 14 start-page: 751 year: 2009 end-page: 761 ident: bib46 article-title: Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007 publication-title: Antivir Ther contributor: fullname: Zambon – volume: 52 start-page: 2667 year: 2009 ident: 10.1016/j.imu.2019.100284_bib20 article-title: A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase publication-title: J Med Chem doi: 10.1021/jm800455g contributor: fullname: An – volume: 11 start-page: 223 year: 2011 ident: 10.1016/j.imu.2019.100284_bib1 article-title: Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(11)70008-1 contributor: fullname: Gessner – volume: 56 start-page: 1747 year: 2011 ident: 10.1016/j.imu.2019.100284_bib6 article-title: Special features of the 2009 pandemic swine-origin influenza AH1N1 hemagglutinin and neuraminidase publication-title: Chin Sci Bull doi: 10.1007/s11434-011-4517-9 contributor: fullname: Vavricka – volume: 303 start-page: 35 year: 1983 ident: 10.1016/j.imu.2019.100284_bib11 article-title: Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A0 resolution publication-title: Nature doi: 10.1038/303035a0 contributor: fullname: Varghese – volume: 443 start-page: 45 year: 2006 ident: 10.1016/j.imu.2019.100284_bib16 article-title: The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design publication-title: Nature doi: 10.1038/nature05114 contributor: fullname: Russell – volume: 7 year: 2011 ident: 10.1016/j.imu.2019.100284_bib30 article-title: Structural and functional analysis of Laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA Inhibition publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002249 contributor: fullname: Vavricka – year: 2018 ident: 10.1016/j.imu.2019.100284_bib2 contributor: fullname: WHO – volume: 9 year: 2013 ident: 10.1016/j.imu.2019.100284_bib15 article-title: New world bats harbor diverse influenza A viruses publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003657 contributor: fullname: Tong – volume: 90 start-page: 5636 year: 2016 ident: 10.1016/j.imu.2019.100284_bib3 article-title: Pathogenesis of influenza D virus in cattle publication-title: J Virol doi: 10.1128/JVI.03122-15 contributor: fullname: Ferguson – volume: 109 start-page: 4269 year: 2012 ident: 10.1016/j.imu.2019.100284_bib14 article-title: A distinct lineage of influenza a virus from bats publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1116200109 contributor: fullname: Tong – volume: 64 start-page: 88 year: 2008 ident: 10.1016/j.imu.2019.100284_bib27 article-title: The protein Data Bank: a historical perspective publication-title: Acta Crystallogr A Found Crystallogr doi: 10.1107/S0108767307035623 contributor: fullname: Berman – volume: 303 start-page: 41 year: 1983 ident: 10.1016/j.imu.2019.100284_bib18 article-title: Structure of the catalytic and antigenic sites in influenza virus neuraminidase publication-title: Nature doi: 10.1038/303041a0 contributor: fullname: Colman – year: 2005 ident: 10.1016/j.imu.2019.100284_bib41 contributor: fullname: Cole – volume: 10 start-page: 689 year: 2001 ident: 10.1016/j.imu.2019.100284_bib31 article-title: Analysis of inhibitor binding in influenza virus neuraminidase publication-title: Protein Sci doi: 10.1110/ps.41801 contributor: fullname: Smith – volume: 53 start-page: 119 year: 2013 ident: 10.1016/j.imu.2019.100284_bib48 article-title: Pharmacokinetic properties of anti- influenza neuraminidase inhibitors publication-title: J Clin Pharmacol doi: 10.1177/0091270012440280 contributor: fullname: Chairat – volume: 6 start-page: 187 year: 2013 ident: 10.1016/j.imu.2019.100284_bib50 article-title: Influenza treatment and prophylaxis with neuraminidase inhibitors: a review publication-title: Infect Drug Resist contributor: fullname: Kamali – volume: 58 start-page: 113 year: 2013 ident: 10.1016/j.imu.2019.100284_bib47 article-title: Antiviral agents targeting the influenza virus: a review and publication analysis publication-title: Vet Med doi: 10.17221/6746-VETMED contributor: fullname: Eyer – volume: 23 start-page: 1858 year: 2009 ident: 10.1016/j.imu.2019.100284_bib9 article-title: Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense publication-title: FASEB J doi: 10.1096/fj.08-119131 contributor: fullname: Kesimer – volume: 12 start-page: 159 year: 2002 ident: 10.1016/j.imu.2019.100284_bib4 article-title: Functional balance between haemagglutinin and neuraminidase in influenza virus infections publication-title: Rev Med Virol doi: 10.1002/rmv.352 contributor: fullname: Wagner – volume: 7 start-page: 450 year: 2016 ident: 10.1016/j.imu.2019.100284_bib29 article-title: Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections publication-title: Front Microbiol doi: 10.3389/fmicb.2016.00450 contributor: fullname: Alame – start-page: 727 year: 1997 ident: 10.1016/j.imu.2019.100284_bib40 article-title: Development and validation of a genetic algorithm for flexible docking publication-title: J Mol Biol doi: 10.1006/jmbi.1996.0897 contributor: fullname: Jones – volume: 337 start-page: 199 year: 2012 ident: 10.1016/j.imu.2019.100284_bib5 article-title: An overlapping protein-coding region in influenza A virus segment 3 modulates the host response publication-title: Science doi: 10.1126/science.1222213 contributor: fullname: Jagger – volume: 60 start-page: 2256 year: 2004 ident: 10.1016/j.imu.2019.100284_bib36 article-title: Secondary-structure matching (SSM), a new tool for fast Protein structure alignment in three dimensions publication-title: Acta Crystallogr D Biol Crystallogr doi: 10.1107/S0907444904026460 contributor: fullname: Krissinel – volume: 221 start-page: 473 year: 1991 ident: 10.1016/j.imu.2019.100284_bib22 article-title: Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution publication-title: J Mol Biol doi: 10.1016/0022-2836(91)80068-6 contributor: fullname: Varghese – volume: 14 start-page: 751 year: 2009 ident: 10.1016/j.imu.2019.100284_bib46 article-title: Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007 publication-title: Antivir Ther doi: 10.3851/IMP1194 contributor: fullname: Tashiro – volume: 10 start-page: 39 year: 2019 ident: 10.1016/j.imu.2019.100284_bib19 article-title: Influenza virus neuraminidase structure and functions publication-title: Front Microbiol doi: 10.3389/fmicb.2019.00039 contributor: fullname: McAuley – volume: 203 start-page: 25 year: 2011 ident: 10.1016/j.imu.2019.100284_bib42 article-title: Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors publication-title: J Infect Dis doi: 10.1093/infdis/jiq010 contributor: fullname: Pizzorno – volume: 49 start-page: 4515 year: 2005 ident: 10.1016/j.imu.2019.100284_bib43 article-title: Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.49.11.4515-4520.2005 contributor: fullname: Mishin – volume: 6 start-page: 245 year: 2012 ident: 10.1016/j.imu.2019.100284_bib8 article-title: Influenza neuraminidase publication-title: Influenza Other Respir Viruses doi: 10.1111/j.1750-2659.2011.00304.x contributor: fullname: Air – volume: 10 start-page: 1581 year: 2017 ident: 10.1016/j.imu.2019.100284_bib10 article-title: The cell surface mucin MUC1 limits the severity of influenza A virus infection publication-title: Mucosal Immunol doi: 10.1038/mi.2017.16 contributor: fullname: McAuley – volume: 6 year: 2010 ident: 10.1016/j.imu.2019.100284_bib45 article-title: Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000786 contributor: fullname: Kiso – volume: 29 start-page: 221 year: 2001 ident: 10.1016/j.imu.2019.100284_bib38 article-title: PDBsum: summaries and analyses of PDB structures publication-title: Nucleic Acids Res doi: 10.1093/nar/29.1.221 contributor: fullname: Laskowski – volume: 53 start-page: 4845 year: 2009 ident: 10.1016/j.imu.2019.100284_bib44 article-title: CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favourable long-retention profile in the mouse respiratory tract publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00731-09 contributor: fullname: Koyama – volume: 176 start-page: S62 year: 1997 ident: 10.1016/j.imu.2019.100284_bib26 article-title: Design of aromatic inhibitors of influenza virus neuraminidase publication-title: J Infect Dis doi: 10.1086/514178 contributor: fullname: Luo – volume: 53 start-page: 633 year: 2010 ident: 10.1016/j.imu.2019.100284_bib7 article-title: In silico characterization of the functional and structural modules of the hemagglutinin protein from the swine-origin influenza virus A (H1N1)-2009 publication-title: Sci China Life Sci doi: 10.1007/s11427-010-4010-8 contributor: fullname: Sun – volume: 7 start-page: 1527 year: 2012 ident: 10.1016/j.imu.2019.100284_bib49 article-title: Recent advances in neuraminidase inhibitor development as anti-influenza drugs publication-title: ChemMedChem doi: 10.1002/cmdc.201200155 contributor: fullname: Feng – volume: 14 start-page: 327 year: 1992 ident: 10.1016/j.imu.2019.100284_bib23 article-title: The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor publication-title: Proteins doi: 10.1002/prot.340140302 contributor: fullname: Varghese – volume: 263 start-page: 6421 year: 1988 ident: 10.1016/j.imu.2019.100284_bib17 article-title: Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)68802-7 contributor: fullname: Bossart – volume: 4 start-page: 1081 year: 1995 ident: 10.1016/j.imu.2019.100284_bib24 article-title: Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase publication-title: Protein Sci doi: 10.1002/pro.5560040606 contributor: fullname: Varghese – volume: 7 start-page: 25 year: 2012 ident: 10.1016/j.imu.2019.100284_bib28 article-title: Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance publication-title: Influenza Other Respir Viruses doi: 10.1111/irv.12047 contributor: fullname: McKimm-Breschkin – volume: 8 start-page: 127 year: 1995 ident: 10.1016/j.imu.2019.100284_bib37 article-title: LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions publication-title: Protein Eng doi: 10.1093/protein/8.2.127 contributor: fullname: Wallace – volume: 78 start-page: 95 year: 2009 ident: 10.1016/j.imu.2019.100284_bib21 article-title: New antivirals and drug resistance publication-title: Annu Rev Biochem doi: 10.1146/annurev.biochem.78.082207.084029 contributor: fullname: Colman – volume: 22 start-page: 1658 year: 2006 ident: 10.1016/j.imu.2019.100284_bib34 article-title: A fast program for clustering and comparing large sets of protein or nucleotide sequences publication-title: Bioinformatics doi: 10.1093/bioinformatics/btl158 contributor: fullname: Li – volume: 7 start-page: 539 year: 2011 ident: 10.1016/j.imu.2019.100284_bib33 article-title: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega publication-title: Mol Syst Biol doi: 10.1038/msb.2011.75 contributor: fullname: Sievers – volume: 35 start-page: 1547 year: 2018 ident: 10.1016/j.imu.2019.100284_bib35 article-title: Molecular evolutionary genetics analysis across computing platforms publication-title: Mol Biol Evol doi: 10.1093/molbev/msy096 contributor: fullname: Kumar – volume: 404 start-page: 215 year: 2010 ident: 10.1016/j.imu.2019.100284_bib12 article-title: In vitro characterization of naturally occurring influenza H3NA-viruses lacking the NA gene segment: toward a new mechanism of viral resistance? publication-title: Virology doi: 10.1016/j.virol.2010.04.030 contributor: fullname: Moules – volume: 17 start-page: 295 year: 2015 ident: 10.1016/j.imu.2019.100284_bib13 article-title: Influenza vaccines: challenges and solutions publication-title: Cell Host Microbe doi: 10.1016/j.chom.2015.02.012 contributor: fullname: Houser – volume: 38 start-page: 3217 year: 1995 ident: 10.1016/j.imu.2019.100284_bib25 article-title: Structure based inhibitors of Influenza virus sialidase. A benzoic acid lead with novel interaction publication-title: J Med Chem doi: 10.1021/jm00017a005 contributor: fullname: Singh – start-page: 3431 year: 2018 ident: 10.1016/j.imu.2019.100284_bib32 article-title: Inhibition of sialidase activity as a therapeutic approach publication-title: Drug Des Dev Ther doi: 10.2147/DDDT.S176220 contributor: fullname: Glanz – volume: 1 start-page: 12 year: 2009 ident: 10.1016/j.imu.2019.100284_bib39 article-title: Software: small molecule Subgraph detector (SMSD) toolkit publication-title: J Cheminf doi: 10.1186/1758-2946-1-12 contributor: fullname: Rahman |
SSID | ssj0001763575 |
Score | 2.1888337 |
Snippet | Influenza virus is an enveloped virus having segmented genome, coded by eight (negative-sense) RNA segments. The RNA segments are packed in a nucleocapsid... |
SourceID | doaj crossref elsevier |
SourceType | Open Website Aggregation Database Publisher |
StartPage | 100284 |
SubjectTerms | Antivirals Computational analysis Docking Drugs Influenza A virus Neuraminidase |
Title | Computational analysis of drug like candidates against Neuraminidase of Human Influenza A virus subtypes |
URI | https://dx.doi.org/10.1016/j.imu.2019.100284 https://doaj.org/article/21c935ec965843e7ac22a9bd5515799a |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwELUQLCwIBIjyJQ9MSBGtY8fxCIiqIAELSBVLdLEdKB8tahoGfj13dorKgFhYMkRWHL1LdO9dLu8YO0o1-NLmNpFK-UQ6ZxJQHsUKZEaXVhvn6Ivu9U02uJdXQzVcGPVFPWHRHjgCdyJ61qTKWzIpkanXYIUAUzrM9EobE6lR1yyIqVBdCT5rKkyWUwLfaJnPP2mG5q7RW0NtXSY4kObyR1IK3v0LuWkh3_TX2VpLFPlpvMENtuTHm-wpDmFoC3gcWkcRPqm4mzaP_HX04rmlP1VIyNccHlH41zNOFhxALiIOkxatDrV7fhknlHwCP-Ufo2lT87opqShbb7H7_sXd-SBpZyUklkYNJb0c0ky6CtWTsohxhbRMZyDBCTz2MouyxCI58Fp0oZuWXmkBIEpAheB1btNttjyejP0O4-TnUvVSELJCulFZAFNBLq3Qlvyxsg47noNVvEdLjGLeK_ZcILIFIVtEZDvsjOD8Xkhu1uEExrhoY1z8FeMOk_NgFC0xiAkfLzX6fe_d_9h7j60Kktih6rLPlmfTxh8gD5mVh-GRO2QrN-fD24cvBhjawg |
link.rule.ids | 315,783,787,867,2109,4031,27935,27936,27937 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Computational+analysis+of+drug+like+candidates+against+Neuraminidase+of+Human+Influenza+A+virus+subtypes&rft.jtitle=Informatics+in+medicine+unlocked&rft.au=Selvaraj%2C+Gracy+Fathima&rft.au=Piramanayagam%2C+Shanmugavel&rft.au=Devadasan%2C+Velmurugan&rft.au=Hassan%2C+Sameer&rft.date=2020&rft.issn=2352-9148&rft.eissn=2352-9148&rft.volume=18&rft.spage=100284&rft_id=info:doi/10.1016%2Fj.imu.2019.100284&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_imu_2019_100284 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-9148&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-9148&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-9148&client=summon |